Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications

Area of Science:

• Cardiology
• Hypertension Research
• Vascular Biology

Background:

• Cardiovascular risk in hypertensive patients is multifactorial, extending beyond blood pressure levels.
• Associated cardiovascular risk factors, comorbidities, and target organ damage significantly influence event risk.
• Emerging evidence implicates sympathetic nervous system activity and blood pressure variability in hypertension-related cardiovascular risk.

Purpose of the Study:

• To review current evidence on the link between sympathetic activation and blood pressure variability in hypertensive patients.
• To analyze the impact of sympathetic overdrive and blood pressure variability on the cardiovascular risk profile.
• To synthesize recent findings on these under-investigated risk factors in hypertension.

Main Methods:

• Literature review of recent studies (past few years).
• Analysis of evidence linking sympathetic activity, blood pressure variability, and cardiovascular outcomes.
• Synthesis of findings related to hypertension and cardiovascular risk.

Main Results:

• Sympathetic overdrive is a recognized factor contributing to increased cardiovascular risk in hypertension.
• Alterations in blood pressure variability are also detected in hypertensive patients and linked to heightened cardiovascular risk.
• The interplay between sympathetic activity and blood pressure variability significantly modulates the overall cardiovascular risk profile.

Conclusions:

• Sympathetic activation and altered blood pressure variability are significant contributors to cardiovascular risk in hypertensive individuals.
• These factors, alongside traditional risk factors, are crucial for a comprehensive risk assessment.
• Further research into modulating sympathetic activity and blood pressure variability may offer novel therapeutic strategies for hypertension management.